Proof-of-Concept Study of Liposomes with a Set of SARS-CoV-2 Viral T-Cell Epitopes as a Vaccine

D. S. Tretiakova; Третьякова Д. С.; E. V. Svirshchevskaya; Свирщевская Е. В.; M. V. Konovalova; Коновалова М. В.; K. S. Plokhikh; Плохих К. С.; V. A. Kazakov; Казаков В. А.; G. B. Telegin; Телегин Г. Б.; A. S. Chernov; Чернов А. С.; V. A. Gushchin; Гущин В. А.; D. V. Vasina; Васина Д. В.; N. S. Egorova; Егорова Н. С.; I. A. Boldyrev; Болдырев И. А.; N. R. Onishchenko; Онищенко Н. Р.; A. S. Alekseeva; Алексеева А. С.; E. L. Vodovozova; Водовозова Е. Л.

doi:10.31857/S0132342322060252

Proof-of-Concept Study of Liposomes with a Set of SARS-CoV-2 Viral T-Cell Epitopes as a Vaccine

Авторлар: Tretiakova D.S.¹, Svirshchevskaya E.V.¹, Konovalova M.V.¹, Plokhikh K.S.², Kazakov V.A.³, Telegin G.B.³, Chernov A.S.³, Gushchin V.A.⁴, Vasina D.V.⁴, Egorova N.S.¹, Boldyrev I.A.¹, Onishchenko N.R.¹, Alekseeva A.S.¹, Vodovozova E.L.¹
Мекемелер:
1. Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences
2. National Research Center “Kurchatov Institute”
3. Pushchino Branch of Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences
4. Gamaleya National Research Center for Epidemiology and Microbiology, Ministry of Healthcare of the Russian Federation
Шығарылым: Том 49, № 1 (2023)
Беттер: 48-64
Бөлім: Articles
URL: https://journals.rcsi.science/0132-3423/article/view/145868
DOI: https://doi.org/10.31857/S0132342322060252
EDN: https://elibrary.ru/POMUEE
ID: 145868

Дәйексөз келтіру

Толық мәтін

Ашық рұқсат
Рұқсат жабық

Рұқсат берілді
Рұқсат жабық

Тек жазылушылар үшін

Аннотация
Авторлар туралы
Әдебиет тізімі
Қосымша файлдар
Статистика

Аннотация

Potential nonameric epitopes of CD8⁺ T lymphocytes were selected from the composition of structural, accessory, and non-structural proteins of SARS-CoV-2 virus (13 peptides) and a 15-mer epitope of CD4⁺ T lymphocytes, from the S-protein, based on the analysis of publications on genome-wide immunoinformatic analysis of T-cell epitopes of the virus (Wuhan strain), as well as a number of clinical studies of immunodominant epitopes among patients recovering from COVID-19 disease. The peptides were synthesized and five compositions of 6–7 peptides were included in liposomes from egg phosphatidylcholine and cholesterol (~200 nm size) obtained by extrusion. After double subcutaneous immunization of conventional mice, activation of cellular immunity was assessed by the level of cytokine synthesis by splenocytes in vitro in response to stimulation with relevant peptide compositions. Liposomal formulation exhibiting the best result in terms of the formation of specific cellular immunity in response to vaccination was selected for further experiments. Evaluation of the protective efficacy of this formulation in an infectious mouse model showed a positive trend in the frequency of occurrence of hyaline-like membranes in the lumen of the alveoli, as well as a somewhat lower severity of microcirculatory disorders. The latter circumstance can potentially help reduce the severity of the disease and prevent its adverse outcomes. A method to produce liposome preparations with peptide compositions for long-term storage is under development.

Негізгі сөздер

Т-cells, epitopes, SARS-CoV-2, vaccines, peptides, liposomes, cytokines

Әдебиет тізімі

Delany I., Rappuoli R., De Gregorio E. // EMBO Mol. Med. 2014. V. 6 (6). P. 708–720.
De Temmerman M.-L., Rejman J., Demeester J., Irvine D.J., Gander B., De Smedt S.C. // Drug Discov. Today. 2011. V. 16 (13-14). P. 569–582.
Reed S., Orr M., Fox C. // Nat. Med. 2013. V. 19. P. 1597–1608.
Kawai T., Akira S. // Nat. Immunol. 2010. V. 11. P. 373–384.
Allison A., Gregoriadis G. // Nature. 1974. V. 252 (5480). P. 252.
Schwendener R.A. // Ther. Adv. Vaccines. 2014. V. 2 (6). P. 159–182.
Perrie Y., Crofts F., Devitt A., Griffiths H.R., Kastner E., Nadella V. // Adv. Drug. Deliv. Rev. 2016. V. 99 (Pt A). P. 85–96.
Nisini R., Poerio N., Mariotti S., De Santis F., Fraziano M. // Front. Immunol. 2018. V. 9. P. 155.
Bernasconi V., Norling K., Bally M., Höök F., Lycke N.Y. // J. Immunol. Res. 2016. V. 2016. P. 5482087.
Третьякова Д.С., Водовозова Е.Л. // Биол. мембраны. 2022. Т. 39. С. 85–106. [Tretiakova D.S., Vodovozova E.L. // Biochem. (Mosc.) Suppl. Ser. A Membr. Cell Biol. 2022. V. 16 (1). P. 1–20.]
Gayed P.M. // Yale J. Biol. Med. 2011. V. 84 (2). P. 131–138.
Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., Akira S. // Nature. 2000. V. 408. P. 740–745.
Lee Y., Lee Y.S., Cho S.Y., Kwon H.J. // Adv. Protein Chem. Struct. Biol. 2015. V. 99. P. 75–97.
Purcell A.W., McCluskey J., Rossjohn J. // Nat. Rev. Drug. Discov. 2007. V. 6 (5). P. 404–414.
Ohno S., Kohyama S., Taneichi M., Moriya O., Hayashi H., Oda H., Mori M., Kobayashi A., Akatsuka T., Uchida T., Matsui M. // Vaccine. 2009. V. 27. P. 3912–3920.
Kohyama S., Ohno S., Suda T., Taneichi M., Yokoyama S., Mori M., Kobayashi A., Hayashi H., Uchida T., Matsui M. // Antiviral Res. 2009. V. 84. P. 168–177.
Heuts J., Varypataki E.M., van der Maaden K., Romeijn S., Drijfhout J.W., van Scheltinga A.T., Ossendorp F., Jiskoot W. // Pharm. Res. 2018. V. 35. P. 207.
Dhakal S., Cheng X., Salcido J., Renu S., Bondra K., Lakshmanappa Y.S., Misch C., Ghimire S., Feliciano-Ruiz N., Hogshead B., Krakowka S., Carson K., McDonough J., Lee C.W., Renukaradhya G.J. // Int. J. Nanomedicine. 2018. V. 13. P. 6699–6715.
Mishra S. // R. Soc. Open Sci. 2020. V. 7. P. 201141.
Fast E., Altman R.B., Chen B. // Potential T-cell and B‑cell Epitopes of 2019-nCoV. bioRxiv preprint. This version posted March 18, 2020. https://doi.org/10.1101/2020.02.19.955484
Kalita P., Padhi A.K., Zhang K.Y.J., Tripathi T. // Microb. Pathogenesis. 2020. V. 145. P. 104236.
Le Bert N., Tan A.T., Kunasegaran K., Tham C.Y.L., Hafezi M., Chia A., Chng M.H.Y., Lin M., Tan N., Linster M., Chia W.N., Chen M.I.-C., Wang L.-F., Ooi E.E., Kalimuddin S., Tambyah P.A., Low J.G.-H., Tan Y.-J., Bertoletti A. // Nature. 2020. V. 584. P. 457–462. https://doi.org/10.1038/s41586-020-2550-z
Ferretti A.P., Tomasz Kula T., Wang Y., Nguyen D.M.V., Weinheime A., Dunlap G.S., Xu Q., Nabilsi N., Perullo C.R., Cristofaro A.W., Whitton H.J., Virbasius A., Olivier K.J., Jr., Buckner L.R., Alistar A.T., Whitman E.D., Bertino S.A., Chattopadhyay S., MacBeath G. // Immunity. 2020. V. 53. P. 1095–1107.e3. https://doi.org/10.1016/j.immuni.2020.10.006
Snyder T.M., Gittelman R.M., Klinger M. // Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection at Both Individual and Population Levels. medRxiv preprint. This version posted August 4, 2020. https://doi.org/10.1101/2020.07.31.20165647
Nelde A., Bilich T., Heitmann J.S., Maringer Y., Salih H.R., Roerden M., Lübke M., Bauer J., Rieth J., Wacker M., Peter A., Hörber S., Traenkle B., Kaiser P.D., Rothbauer U., Becker M., Junker D., Krause G., Strengert M., Schneiderhan-Marra N., Templin M.F., Joos T.O., Kowalewski D.J., Stos-Zweifel V., Fehr M., Rabsteyn A., Mirakaj V., Karbach J., Jäger E., Graf M., Gruber L.-C., Rachfalski D., Preuß B., Hagelstein I., Märklin M., Bakchoul T., Gouttefangeas C., Kohlbacher O., Klein R., Stevanović S., Rammensee H.-G., Walz J.S. // Nat. Immunol. 2021. V. 22. P. 74–85. https://doi.org/10.1038/s41590-020-00808-x
Quadeer A.A., Ahmed S.F., McKay M.R. // Cell Rep. Med. 2021. V. 2. P. 100312. https://doi.org/10.1016/j.xcrm.2021.100312
Mouritsen O.G., Jorgenson K. // Chem. Phys. Lipids. 1994. V. 73. P. 3–25.
Markwell M., Haas S., Bieber L., Tolbert N.E. // Anal. Biochem. 1978. V. 210. P. 206–210.
Chen W., Huang L. // Mol. Pharm. 2008. V. 5. P. 464–471.
Mansourian M., Badiee A., Jalali S.A., Shariat S., Yazdani M., Amin M., Jaafari M.R. // Immunol. Lett. 2014. V. 162. P. 87–93.
Schmidt S.T., Foged C., Korsholm K.S., Rades T., Christensen D. // Pharmaceutics. 2016. V. 8. P. 7.
Ludewig B., Barchiesi F., Pericin M., Zinkernagel R.M., Hengartner H., Schwendener R.A. // Vaccine. 2001. V. 19 (1). P. 23–32.
Engler O.B., Schwendener R.A., Dai W.J., Wolk B., Pichler W., Moradpour D., Brunner T., Cerny A. // Vaccine. 2004. V. 23 (1). P. 58–68.
Dalwadi G, Benson HA, Chen Y. // Pharm. Res. 2005. V. 22 (12). P. 2152–2162.
Dedoni S., Avdoshina V., Camoglio C., Siddi C., Fratta W., Scherma M., Fadda P. // Molecules. 2022. V. 27 (13). P. 4142.
Kryukova E.V., Egorova N.S., Kudryavtsev D.S., Lebedev D.S., Spirova E.N., Zhmak M.N., Garifulina A.I., Kasheverov I.E., Utkin Y.N., Tsetlin V.I. // Front. Pharmacol. 2019. V. 10. P. 748.
Tkachuk A.P., Gushchin V.A., Potapov V.D., Demidenko A.V., Lunin V.G., Gintsburg A.L. // PLoS One. 2017. V. 12 (4). P. e0176784.
Chernov A.S., Minakov A.A., Kazakov V.A., Rodionov M.V., Rybalkin I.N., Vlasik T.N., Yashin D.V., Saschenko L.P., Kudriaeva A.A., Belogurov A.A., Smirnov I.V., Loginova S.Y., Schukina V.N., Savenko S.V., Borisevich S.V., Zykov K.A., Gabibov A.G., Telegin G.B. // Inflamm. Res. 2022. V. 71 (5–6). P. 627–639.
Mann P.C., Vahle J., Keenan C.M., Baker J.F., Bradley A.E., Goodman D.G., Harada T., Herbert R., Kaufmann W., Kellner R., Nolte T., Rittinghausen S., Tanaka T. // Toxicol. Pathol. 2012. V. 40 (Suppl. 4). P. 7S–13S.